TNDM Tandem Diabetes Care, Inc.

16.80USD-1.47%Mkt Cap: 1.17B USDP/E: —

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery sy…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap1.17B USD
Enterprise Value1.48B USD
Revenue (TTM)1.08B USD
Gross Profit546.01M USD
Net Income (TTM)-204.71M USD
Revenue/Share15.64 USD
Last Price16.80 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)188.09
PEG—
EV/EBITDA-202.68
EV/Revenue1.38
P/S1.09
P/B8.67
EPS (TTM)-0.65 USD
EPS (Forward)0.10 USD
52W Range
12.2626% of range29.65
52W High29.65 USD
52W Low12.26 USD
Profitability
Gross Margin53.81%
Oper. Margin-2.35%
EBITDA Margin-0.68%
Profit Margin-20.17%
ROE-131.93%
ROA-23.23%
ROIC-54.50%
ROCE-26.21%
Growth
Revenue Growth13.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.72M USD
CapEx (TTM)98.54M USD
FCF Margin-6.09%
FCF Yield-5.59%
Net Debt293.46M USD
Net Debt/EBITDA-40.10
Net Debt/FCF—
Balance Sheet
Debt/Equity2.86
Current Ratio3.21
Quick Ratio2.43
Book Value/Sh1.94 USD
Cash/Share6.35 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 10, 2017
Splits
Last Split1:10
Split DateOct 10, 2017
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.10 USD
Upside (mean)+61.3%
Target Range18.00 USD – 50.00 USD
18.00+61.3% to mean50.00
# Analysts21
Ownership
Shares Out.69.79M
Float63.97M
Insiders1.18%
Institutions117.71%
Short Interest
Short Ratio7.4d
Short % Float31.02%
Short % Out.23.18%
Shares Short16.17M
Short (prev mo.)13.37M
Technical
SMA 5017.37 (-3.3%)
SMA 20018.83 (-10.8%)
Beta1.59
S&P 52W Chg12.08%
Avg Vol (30d)2.57M
Avg Vol (10d)3.24M
Technical Indicators
RSI (14)44.8
MACD-0.0159
MACD Signal0.1859
MACD Hist.-0.2017
BB Upper20.37 USD
BB Middle18.35 USD
BB Lower16.33 USD
BB Width22.02%
ATR (14)1.416 USD
Vol Ratio (20d)0.80x

About Tandem Diabetes Care (NASDAQ: TNDM)

›

Tandem Diabetes Care (NASDAQ: TNDM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 2,500 employees.

The shares were at 16.80 USD on 19 November 2026, up 14.5% over 52 weeks. Its 52-week range is 12.26 USD to 29.65 USD: the price is 43.3% below the high and 37.0% above the low.

Its market capitalisation is 1.17B USD.

Tandem Diabetes Care reports return on equity of -131.9%, an operating margin of -2.4% and revenue up 13.8% year over year.

Its debt exceeds its cash by 293.46M USD, a debt-to-equity ratio of 2.86. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 27.10 USD is 61.3% above the current price. The next earnings report is expected on 18 February 2027.